Keytruda
Showing 926 - 945 of 945
Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)
Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in
Active, not recruiting
- Acral Lentiginous Melanoma
- +3 more
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +822 more
Jan 28, 2023
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in Puerto Rico, United States
Active, not recruiting
- Rectal Adenocarcinoma
- +2 more
- Capecitabine
- +6 more
-
Birmingham, Alabama
- +649 more
Aug 5, 2022
Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal
Active, not recruiting
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- +10 more
- Biospecimen Collection
- +9 more
-
Birmingham, Alabama
- +922 more
Jan 28, 2023
Head Neck Cancer Trial in Chicago (Pembrolizumab, epacadostat)
Withdrawn
- Head and Neck Cancer
-
Chicago, IllinoisUniversity of Chicago
Jan 2, 2018
Pathologic Stage I Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Merkel
Recruiting
- Pathologic Stage I Merkel Cell Carcinoma AJCC v8
- +4 more
- Best Practice
- +5 more
-
Birmingham, Alabama
- +552 more
Aug 23, 2022
Carcinoma, Non-small-cell Lung, Mesothelioma, Pancreatic Tumors Trial in United Kingdom (Defactinib, Pembrolizumab)
Unknown status
- Carcinoma, Non-small-cell Lung
- +2 more
-
Belfast, United Kingdom
- +4 more
Mar 16, 2018
Breast Tumors, Bone Tumors Trial in Melbourne (Stereotactic Ablative Body Radiosurgery (SABR), MK-3475)
Completed
- Breast Neoplasms
- Bone Neoplasms
- Stereotactic Ablative Body Radiosurgery (SABR)
- MK-3475
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Oct 17, 2017
Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial in Canada,
Recruiting
- Lung Non-Squamous Non-Small Cell Carcinoma
- +5 more
- Carboplatin
- +2 more
-
Mobile, Alabama
- +1065 more
Jan 31, 2023
Non Small Cell Lung Cancer, Metastasis, Recurrence Trial in Augusta (Pembrolizumab, Idelalisib)
Unknown status
- Non Small Cell Lung Cancer
- +2 more
-
Augusta, GeorgiaGeorgia Cancer Center at Augusta University
Sep 27, 2017
Solid Tumor Trial (pd-1 and DC-NK cells)
Unknown status
- Solid Tumor
- pd-1 and DC-NK cells
- (no location specified)
Jan 28, 2019
Solid Tumor Trial (pd-1 and dc-cik cells)
Unknown status
- Solid Tumor
- pd-1 and dc-cik cells
- (no location specified)
Jan 28, 2019
Estrogen Receptor Negative, HER2/Neu Negative, Metastatic Breast Cancer Trial in Seattle (Pembrolizumab, Cisplatin)
Withdrawn
- Estrogen Receptor Negative
- +5 more
- Pembrolizumab
- Cisplatin
-
Seattle, WashingtonSeattle Cancer Care Alliance, Fred Hutch/University of Washingto
Apr 24, 2019
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma Trial in Guam,
Recruiting
- Lung Non-Small Cell Carcinoma
- +7 more
- Carboplatin
- +8 more
-
Anchorage, Alaska
- +1084 more
Aug 24, 2022
Lung Adenocarcinoma, Lung Large Cell Carcinoma, Resectable Lung Non-Small Cell Carcinoma Trial in Guam, Puerto Rico, United
Recruiting
- Lung Adenocarcinoma
- +12 more
- Carboplatin
- +12 more
-
Birmingham, Alabama
- +1612 more
Aug 23, 2022
Cancer, Breast Cancer, Colorectal Cancer Trial in Genoa (Prolon)
Unknown status
- Cancer
- +2 more
- Prolon
-
Genoa, GE, ItalyAlessio Nencioni
Jul 31, 2018
Stage IV Melanoma Trial in Louisville (A-dmDT390-bisFv(UCHT1), Pembrolizumab, Ionizing Radiation)
Unknown status
- Stage IV Melanoma
- A-dmDT390-bisFv(UCHT1)
- +2 more
-
Louisville, KentuckyJames Graham Brown Cancer Center
Dec 12, 2016